Comparison Between Surgical Excision and Ultrasound Guided Evacuation in Management of Cesarean Section Scar Pregnancy.

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-45
SponsorSohag University

About this trial

patients diagnosed with cesarean section scar ectopic pregnancy type II will be divided into two groups, one will undergo surgical excision and the other one will undergo ultrasound-guided evacuation in order to compare safety and efficacy of both techniques.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

patients diagnosed with cesarean scar ectopic pregnancy Type II in the 1st trimester.

Disqualifiers

patients with cesarean scar pregnancy type 2 above 14 weeks.

Type I and type III cesarean section scar pregnancy.

patients presented with massive bleeding or shock.

Heterotopic pregnancy.

Trial population

patients diagnosed with cesarean section scar ectopic pregnancy type II and undergoing treatment in sohag university hospital.

Trial design

Design model

Case-control

Time perspective

Retrospective

Treatments tested in this trial

  • surgical excision of cesarean section scar ectopic pregnancy

    Procedure/Surgery

    surgical excision by laparotomy.

  • ultrasound guided evacuation of cesarean section scar ectopic pregnancy

    Procedure/Surgery

    ultrasound guided evacuation of cesarean section scar ectopic pregnancy trans-cervically.

Treatment groups

68 Participants
are divided into 2 treatment groups
Group A: ultrasound guided evacuation1 intervention
Group B: surgical excision1 intervention

Trial outcomes

Primary outcomes

1

efficacy of surgical excision versus ultrasound guided evacuation of cesarean section scar ectopic pregnancy.

Time frame
1 year

Secondary outcomes

1

hematoma formation

Time frame
1 year
2

bleeding above 1 liter

Time frame
1 year
3

recurrence of cesarean section scar ectopic

Time frame
3 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.